Acceptance and Examination of Chemical APIs
Tuesday, 25 January 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Procedures for initiating verification and testing of drug registration (Trial) in 2022

On December 20, 2022, the CDE (Center for Drug Evaluation) published (No.54-2021) the trial working
Tuesday, 25 January 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

CDE announces Latest Consultation Arrangements

Considering the current requirements for epidemic prevention and control and the need of innovative drug
Monday, 20 December 2021 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Annual Report on New Drug Clinical Trial Applications in 2020

On November 10, 2021, the CDE (Center for Drug Evaluation) under the NMPA (National Medical
Monday, 20 December 2021 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Important Items in China Pre-NDA Meetings for Innovative Drug Approvals

On November 26, 2021, the CDE (Center for Drug Evaluation) under the NMPA (National Medical